|
|
|
|
To optimize productivity for complex proteins, biopharmaceutical researchers should utilize technology platforms and experienced CDMOs. This approach mitigates challenges associated with CLD.
|
|
|
|
|
Scale-out biomanufacturing enhances flexibility, speeds timelines, lowers risk, and enables efficient parallel production for scalable, resilient biologics and advanced therapies.
|
|
|
|
|
Product quality assessments revealed that a customer’s therapeutic protein had a range of hydrophobic HCPs. Review a solution that took an alternative approach by utilizing cell line engineering.
|
|
|
|
|
PCC boosts Protein A capture efficiency, cuts resin costs, increases productivity, and enables continuous downstream processing without sacrificing quality or compliance.
|
|
|
|
|
|
|
|
|
